Compare FOXF & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FOXF | CTKB |
|---|---|---|
| Founded | 2007 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Motor Vehicles | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 618.2M | 652.1M |
| IPO Year | N/A | 2021 |
| Metric | FOXF | CTKB |
|---|---|---|
| Price | $19.10 | $5.37 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 5 |
| Target Price | ★ $30.67 | $5.70 |
| AVG Volume (30 Days) | 570.9K | ★ 785.4K |
| Earning Date | 02-26-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,459,086,000.00 | $196,828,000.00 |
| Revenue This Year | $6.82 | $0.08 |
| Revenue Next Year | $3.63 | $5.45 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 6.22 | N/A |
| 52 Week Low | $13.08 | $2.37 |
| 52 Week High | $31.18 | $6.18 |
| Indicator | FOXF | CTKB |
|---|---|---|
| Relative Strength Index (RSI) | 60.63 | 51.55 |
| Support Level | $18.90 | $5.21 |
| Resistance Level | $19.94 | $5.70 |
| Average True Range (ATR) | 0.71 | 0.26 |
| MACD | 0.05 | -0.01 |
| Stochastic Oscillator | 69.32 | 38.64 |
Fox Factory Holding Corp is a designer, manufacturer, and marketer of performance-defining products and systems used predominantly on bikes, Side-by-Sides, on-road vehicles with and without off-road capabilities, off-road vehicles and trucks, ATVs, snowmobiles, specialty vehicles and applications, motorcycles, and commercial trucks. Its business operates under the FOX, FOX RACING SHOX, and RACE FACE brands. Geographically, it derives a majority of revenue from North America and also has a presence in Asia, Europe, and the Rest of the World.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.